| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 4.88B | 4.79B | 4.87B | 4.53B | 4.42B |
| Gross Profit | 562.00M | 518.60M | 495.50M | 493.50M | 468.00M |
| EBITDA | 515.60M | 326.90M | 448.90M | 382.00M | 371.50M |
| Net Income | 145.60M | 44.20M | 202.40M | 155.40M | 303.90M |
Balance Sheet | |||||
| Total Assets | 2.80B | 2.66B | 2.61B | 2.75B | 2.73B |
| Cash, Cash Equivalents and Short-Term Investments | 199.30M | 183.00M | 94.40M | 57.20M | 198.40M |
| Total Debt | 909.30M | 806.40M | 659.90M | 708.90M | 807.30M |
| Total Liabilities | 1.92B | 1.82B | 1.58B | 1.72B | 1.73B |
| Stockholders Equity | 873.60M | 842.50M | 1.03B | 1.03B | 1.01B |
Cash Flow | |||||
| Free Cash Flow | 405.60M | 385.00M | 368.40M | 307.80M | 317.80M |
| Operating Cash Flow | 427.10M | 419.40M | 393.10M | 327.20M | 349.90M |
| Investing Cash Flow | -279.50M | -7.40M | -5.40M | -35.30M | -232.30M |
| Financing Cash Flow | -127.80M | -322.30M | -347.90M | -436.80M | -250.10M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | £2.34B | 16.25 | 16.69% | 1.27% | 1.69% | 276.44% | |
73 Outperform | £8.91B | 26.06 | 31.07% | 3.44% | 1.13% | 1.73% | |
65 Neutral | £10.78B | 35.58 | 6.51% | 1.68% | -3.59% | 15.83% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | £1.91B | 24.52 | 15.86% | 2.58% | 10.55% | -19.05% | |
54 Neutral | £345.12M | 272.92 | 0.58% | 2.31% | 10.68% | -89.58% | |
45 Neutral | £382.69M | -2.31 | -142.88% | ― | -7.30% | -311.68% |